InsiderTrades.com logo

HALO Insider Trading

Insider Ownership Percentage: 2.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $15,457,803.70

Halozyme Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Halozyme Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Halozyme Therapeutics Share Price & Price History

Current Price: $77.94
Price Change: ▲ Price Increase of +1.459 (1.91%)
As of 02/4/2026 04:59 PM ET

This chart shows the closing price history over time for HALO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Halozyme Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2026Bernadette ConnaughtonDirectorSell2,000$70.25$140,500.0040,123View SEC Filing Icon  
12/1/2025Bernadette ConnaughtonDirectorSell829$71.60$59,356.4042,123View SEC Filing Icon  
12/1/2025Helen TorleyCEOSell16,569$68.92$1,141,935.48708,719View SEC Filing Icon  
11/11/2025Helen TorleyCEOSell20,000$69.13$1,382,600.00733,719View SEC Filing Icon  
11/10/2025Bernadette ConnaughtonDirectorSell2,000$68.48$136,960.0042,952View SEC Filing Icon  
11/1/2025Cortney CaudillCOOSell4,263$65.19$277,904.9712,737View SEC Filing Icon  
10/3/2025Helen TorleyCEOSell20,000$69.03$1,380,600.00733,719View SEC Filing Icon  
10/1/2025Bernadette ConnaughtonDirectorSell2,000$75.24$150,480.0044,952View SEC Filing Icon  
10/1/2025Helen TorleyCEOSell20,000$75.35$1,507,000.00733,719View SEC Filing Icon  
9/22/2025Nicole LabrosseCFOSell2,227$77.95$173,594.6522,079View SEC Filing Icon  
9/10/2025Nicole LabrosseCFOSell20,000$75.71$1,514,200.0024,306View SEC Filing Icon  
9/3/2025Helen TorleyCEOSell20,000$74.44$1,488,800.00733,719View SEC Filing Icon  
9/2/2025Bernadette ConnaughtonDirectorSell4,000$73.68$294,720.0046,952View SEC Filing Icon  
8/12/2025Helen TorleyCEOSell20,000$63.51$1,270,200.00733,719View SEC Filing Icon  
7/9/2025Helen TorleyCEOSell20,000$56.43$1,128,600.00733,719View SEC Filing Icon  
6/24/2025Helen TorleyCEOSell20,000$53.73$1,074,600.00733,719View SEC Filing Icon  
6/20/2025Helen TorleyCEOSell20,000$52.96$1,059,200.00733,719View SEC Filing Icon  
4/28/2025Jeffrey William HendersonDirectorSell4,497$60.37$271,483.8928,611View SEC Filing Icon  
4/1/2025Jeffrey William HendersonDirectorSell503$64.05$32,217.1533,108View SEC Filing Icon  
3/3/2025Jeffrey William HendersonDirectorSell5,000$58.69$293,450.0033,611View SEC Filing Icon  
2/27/2025Michael J. LaBarreSVPSell1,697$58.28$98,901.16173,756View SEC Filing Icon  
2/25/2025Michael J. LaBarreSVPSell10,000$58.05$580,500.00185,453View SEC Filing Icon  
2/3/2025Jeffrey William HendersonDirectorSell5,000$56.30$281,500.0038,611View SEC Filing Icon  
1/6/2025Jeffrey William HendersonDirectorSell10,000$50.01$500,100.0043,611View SEC Filing Icon  
10/16/2024Michael J. LaBarreSVPSell10,000$53.26$532,600.00173,756View SEC Filing Icon  
10/9/2024Helen TorleyCEOSell10,000$52.58$525,800.00676,744View SEC Filing Icon  
9/25/2024Helen TorleyCEOSell10,000$56.34$563,400.00676,744View SEC Filing Icon  
9/18/2024Michael J. LaBarreSVPSell10,000$62.03$620,300.00173,756View SEC Filing Icon  
9/12/2024Helen TorleyCEOSell10,000$59.20$592,000.00676,744View SEC Filing Icon  
9/10/2024Helen TorleyCEOSell10,000$59.09$590,900.00676,744View SEC Filing Icon  
8/21/2024Michael J. LaBarreSVPSell10,000$61.75$617,500.00168,176View SEC Filing Icon  
8/14/2024Matthew L. PosardDirectorSell9,881$57.70$570,133.7069,874View SEC Filing Icon  
8/12/2024Matthew L. PosardDirectorSell10,000$55.72$557,200.0089,755View SEC Filing Icon  
7/24/2024Michael J. LaBarreSVPSell10,000$55.12$551,200.00168,176View SEC Filing Icon  
7/22/2024Nicole LabrosseCFOSell5,000$53.93$269,650.0015,480View SEC Filing Icon  
6/27/2024Nicole LabrosseCFOSell10,000$51.93$519,300.0015,480View SEC Filing Icon  
6/11/2024Matthew L. PosardDirectorSell10,000$50.01$500,100.00109,755View SEC Filing Icon  
5/22/2024Michael J. LaBarreSVPSell10,000$45.38$453,800.00168,176View SEC Filing Icon  
4/17/2024Michael J. LaBarreSVPSell10,000$38.49$384,900.00168,176View SEC Filing Icon  
3/12/2024Michael J. LaBarreSVPSell10,000$41.64$416,400.00156,558View SEC Filing Icon  
2/28/2024Michael J. LaBarreSVPSell10,000$39.55$395,500.00156,558View SEC Filing Icon  
12/12/2023Michael J. LaBarreSVPSell10,000$39.63$396,300.00151,911View SEC Filing Icon  
10/17/2023Michael J. LaBarreSVPSell10,000$36.52$365,200.00151,911View SEC Filing Icon  
9/19/2023Michael J. LaBarreSVPSell10,000$39.10$391,000.00151,911View SEC Filing Icon  
8/31/2023Helen TorleyCEOSell10,000$42.82$428,200.00623,666View SEC Filing Icon  
8/29/2023Helen TorleyCEOSell10,000$42.40$424,000.00623,666View SEC Filing Icon  
8/22/2023Michael J. LaBarreSVPSell10,000$42.41$424,100.00151,911View SEC Filing Icon  
8/22/2023Michael J. LaBarreSVPSell10,000$42.41$424,100.00151,911View SEC Filing Icon  
8/17/2023Helen TorleyCEOSell10,000$43.18$431,800.00623,666View SEC Filing Icon  
8/14/2023James M. DalyDirectorSell10,000$43.74$437,400.0020,503View SEC Filing Icon  
8/11/2023James M. DalyDirectorSell10,000$43.71$437,100.0030,503View SEC Filing Icon  
7/26/2023Helen TorleyCEOSell10,000$42.69$426,900.00623,666View SEC Filing Icon  
7/18/2023Michael J. LaBarreSVPSell10,000$40.43$404,300.00141,911View SEC Filing Icon  
6/21/2023Michael J. LaBarreSVPSell10,000$36.00$360,000.00141,911View SEC Filing Icon  
4/18/2023Michael J. LaBarreSVPSell10,000$36.00$360,000.00141,911View SEC Filing Icon  
3/9/2023Helen TorleyCEOSell10,000$42.73$427,300.00623,666View SEC Filing Icon  
3/7/2023Helen TorleyCEOSell10,000$45.47$454,700.00623,666View SEC Filing Icon  
3/1/2023Jeffrey William HendersonDirectorSell10,000$47.71$477,100.0039,045View SEC Filing Icon  
2/27/2023Michael J. LaBarreSVPSell10,000$49.55$495,500.00138,927View SEC Filing Icon  
2/16/2023Helen TorleyCEOSell11,061$49.26$544,864.86633,666View SEC Filing Icon  
2/16/2023Nicole LabrosseCFOSell2,525$49.26$124,381.509,066View SEC Filing Icon  
2/15/2023Michael J. LaBarreSVPSell10,000$48.39$483,900.00143,477View SEC Filing Icon  
2/8/2023Helen TorleyCEOSell10,000$51.36$513,600.00587,177View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

97.79% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HALO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Halozyme Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/4/2026VIRGINIA RETIREMENT SYSTEMS ET Al20,769$1.40M0.0%-23.7%0.018%Search for SEC Filing on Google Icon
2/4/2026Swiss Life Asset Management Ltd9,032$0.61M0.0%+55.3%0.008%Search for SEC Filing on Google Icon
2/4/2026Securian Asset Management Inc.8,511$0.57M0.0%-2.8%0.007%Search for SEC Filing on Google Icon
2/4/2026Plato Investment Management Ltd2,257$0.15M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/3/2026Crossmark Global Holdings Inc.3,353$0.23M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/3/2026Ballentine Partners LLC6,262$0.42M0.0%-4.8%0.005%Search for SEC Filing on Google Icon
2/3/2026International Assets Investment Management LLC1,181$79K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/3/2026Diversify Wealth Management LLC21,133$1.52M0.1%+7.0%0.018%Search for SEC Filing on Google Icon
2/3/2026Bernzott Capital Advisors67,794$4.56M2.2%-2.1%0.058%Search for SEC Filing on Google Icon
2/3/2026Sequoia Financial Advisors LLC5,148$0.35M0.0%+30.8%0.004%Search for SEC Filing on Google Icon
2/3/2026Swedbank AB162,062$10.91M0.0%+10.1%0.138%Search for SEC Filing on Google Icon
2/3/2026BOKF NA16,050$1.08M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/3/2026SBI Securities Co. Ltd.1,447$97K0.0%+353.6%0.001%Search for SEC Filing on Google Icon
2/3/2026Gallacher Capital Management LLC6,447$0.43M0.2%-29.2%0.005%Search for SEC Filing on Google Icon
2/2/2026Alliance Wealth Advisors LLC UT12,592$0.85M0.2%-30.2%0.011%Search for SEC Filing on Google Icon
2/2/2026Hussman Strategic Advisors Inc.52,500$3.53M0.9%+66.7%0.045%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio2,779$0.19M0.0%-5.2%0.002%Search for SEC Filing on Google Icon
2/2/2026Artemis Investment Management LLP114,596$7.71M0.1%+14.6%0.097%Search for SEC Filing on Google Icon
2/2/2026Horizon Investments LLC2,908$0.20M0.0%-91.8%0.002%Search for SEC Filing on Google Icon
2/2/2026Fifth Third Bancorp1,582$0.11M0.0%-86.2%0.001%Search for SEC Filing on Google Icon
2/2/2026Danske Bank A S1,300$87K0.0%-97.9%0.001%Search for SEC Filing on Google Icon
1/30/2026Sigma Planning Corp9,592$0.65M0.0%+22.2%0.008%Search for SEC Filing on Google Icon
1/30/2026New York State Teachers Retirement System125,968$8.48M0.0%+0.7%0.107%Search for SEC Filing on Google Icon
1/30/2026Precision Wealth Strategies LLC6,837$0.46M0.1%-34.6%0.006%Search for SEC Filing on Google Icon
1/30/2026Verity Asset Management Inc.53,118$3.58M1.5%+11.6%0.045%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D39,923$2.69M0.0%-9.8%0.034%Search for SEC Filing on Google Icon
1/30/2026Shaker Investments LLC OH18,701$1.26M0.5%-1.5%0.016%Search for SEC Filing on Google Icon
1/30/2026Cardinal Capital Management18,689$1.26M0.2%+5.2%0.016%Search for SEC Filing on Google Icon
1/30/2026Torren Management LLC1,305$88K0.0%N/A0.001%Search for SEC Filing on Google Icon
1/30/2026Mitsubishi UFJ Trust & Banking Corp5,718$0.39M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp26,630$1.79M0.0%-0.8%0.023%Search for SEC Filing on Google Icon
1/29/2026Koa Wealth Management LLC93,108$6.27M4.3%+7.5%0.079%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank67,005$4.51M0.0%-3.1%0.057%Search for SEC Filing on Google Icon
1/29/2026Ashton Thomas Private Wealth LLC9,586$0.65M0.0%+3.7%0.008%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA18,736$1.26M0.0%+4.0%0.016%Search for SEC Filing on Google Icon
1/29/2026James Investment Research Inc.26,562$1.79M0.2%-29.2%0.023%Search for SEC Filing on Google Icon
1/29/2026Verdence Capital Advisors LLC12,346$0.83M0.0%-5.2%0.010%Search for SEC Filing on Google Icon
1/29/2026ST Germain D J Co. Inc.2,628$0.18M0.0%+19.7%0.002%Search for SEC Filing on Google Icon
1/29/2026Sanctuary Advisors LLC29,450$1.98M0.0%+7.7%0.025%Search for SEC Filing on Google Icon
1/29/2026Teachers Retirement System of The State of Kentucky36,951$2.49M0.0%-9.8%0.031%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.11,566,896$778.45M0.0%-0.5%9.836%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.19,162$1.29M0.1%-6.5%0.016%Search for SEC Filing on Google Icon
1/29/2026NBC Securities Inc.11,280$0.76M0.1%-3.1%0.010%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System32,658$2.20M0.0%-10.4%0.028%Search for SEC Filing on Google Icon
1/28/2026Geneos Wealth Management Inc.12,499$0.84M0.0%+1.6%0.011%Search for SEC Filing on Google Icon
1/28/2026HB Wealth Management LLC3,022$0.20M0.0%-4.7%0.003%Search for SEC Filing on Google Icon
1/28/2026Davidson Capital Management Inc.56,223$3.78M0.8%+1.4%0.048%Search for SEC Filing on Google Icon
1/28/2026Boston Trust Walden Corp781,835$52.62M0.4%-6.2%0.665%Search for SEC Filing on Google Icon
1/28/2026Ruffer LLP26,121$1.76M0.1%-13.5%0.022%Search for SEC Filing on Google Icon
1/28/2026M&T Bank Corp11,768$0.79M0.0%-56.2%0.010%Search for SEC Filing on Google Icon
1/27/2026Meritage Portfolio Management86,552$5.83M0.4%-4.0%0.074%Search for SEC Filing on Google Icon
1/27/2026Round Rock Advisors LLC5,259$0.35M0.1%-22.8%0.004%Search for SEC Filing on Google Icon
1/27/2026First Horizon Corp1,223$82K0.0%+58.8%0.001%Search for SEC Filing on Google Icon
1/27/2026Lecap Asset Management Ltd.9,163$0.62M0.2%+15.1%0.008%Search for SEC Filing on Google Icon
1/27/2026Asset Management One Co. Ltd.24,844$1.71M0.0%+1,358.0%0.021%Search for SEC Filing on Google Icon
1/27/2026GF Fund Management CO. LTD.2,310$0.16M0.0%-8.2%0.002%Search for SEC Filing on Google Icon
1/26/2026Moran Wealth Management LLC35,596$2.40M0.1%+0.4%0.030%Search for SEC Filing on Google Icon
1/26/2026Shelton Wealth Management LLC21,212$1.43M0.6%+4.5%0.018%Search for SEC Filing on Google Icon
1/26/2026Campbell Newman Asset Management Inc.35,527$2.39M0.2%-3.7%0.030%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.5,714$0.39M0.0%+10.4%0.005%Search for SEC Filing on Google Icon
1/26/2026Greenwood Capital Associates LLC7,803$0.53M0.1%N/A0.007%Search for SEC Filing on Google Icon
1/26/2026Nations Financial Group Inc. IA ADV14,994$1.01M0.1%-1.1%0.013%Search for SEC Filing on Google Icon
1/26/2026CWM LLC12,458$0.84M0.0%-47.8%0.011%Search for SEC Filing on Google Icon
1/26/2026KBC Group NV3,945$0.27M0.0%+17.4%0.003%Search for SEC Filing on Google Icon
1/23/2026Farther Finance Advisors LLC12,415$0.84M0.0%+7.5%0.011%Search for SEC Filing on Google Icon
1/23/2026Oak Ridge Investments LLC39,638$2.67M0.2%-2.9%0.034%Search for SEC Filing on Google Icon
1/23/2026Assetmark Inc.137,415$9.25M0.0%+11.9%0.117%Search for SEC Filing on Google Icon
1/23/2026AMI Asset Management Corp8,662$0.58M0.0%-28.3%0.007%Search for SEC Filing on Google Icon
1/23/2026State of Alaska Department of Revenue66,909$4.50M0.0%+10.5%0.057%Search for SEC Filing on Google Icon
1/23/2026Tectonic Advisors LLC17,231$1.16M0.1%+4.0%0.015%Search for SEC Filing on Google Icon
1/23/2026Paragon Capital Management Inc.18,920$1.27M1.0%N/A0.016%Search for SEC Filing on Google Icon
1/23/2026Choreo LLC3,075$0.21M0.0%-90.2%0.003%Search for SEC Filing on Google Icon
1/23/2026Sumitomo Mitsui Trust Group Inc.8,500$0.57M0.0%+93.2%0.007%Search for SEC Filing on Google Icon
1/23/2026Ritholtz Wealth Management11,272$0.76M0.0%+28.9%0.010%Search for SEC Filing on Google Icon
1/23/2026Diversify Advisory Services LLC8,573$0.61M0.0%+10.7%0.007%Search for SEC Filing on Google Icon
1/21/2026Yousif Capital Management LLC31,571$2.22M0.0%-1.5%0.027%Search for SEC Filing on Google Icon
1/21/2026Azzad Asset Management Inc. ADV12,121$0.82M0.1%+1.6%0.010%Search for SEC Filing on Google Icon
1/20/2026Sugar Maple Asset Management LLC12,800$0.86M0.6%+24.3%0.011%Search for SEC Filing on Google Icon
1/20/2026Element Squared LLC17,726$1.19M0.6%N/A0.015%Search for SEC Filing on Google Icon
1/16/2026MRA Advisory Group7,395$0.50M0.2%-14.2%0.006%Search for SEC Filing on Google Icon
1/16/2026Linden Thomas Advisory Services LLC34,803$2.34M0.2%-1.3%0.030%Search for SEC Filing on Google Icon
1/16/2026Tema Etfs LLC25,256$1.70M0.1%N/A0.021%Search for SEC Filing on Google Icon
1/15/2026Nisa Investment Advisors LLC3,018$0.20M0.0%-35.3%0.003%Search for SEC Filing on Google Icon
1/15/2026Foster & Motley Inc.22,832$1.54M0.1%-1.6%0.019%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC29,938$2.11M0.0%+6.5%0.025%Search for SEC Filing on Google Icon
1/15/2026Retirement Systems of Alabama370,911$24.96M0.1%-0.1%0.315%Search for SEC Filing on Google Icon
1/14/2026Redhawk Wealth Advisors Inc.36,017$2.42M0.3%-1.5%0.031%Search for SEC Filing on Google Icon
1/14/2026Spire Wealth Management8,676$0.58M0.0%+75.1%0.007%Search for SEC Filing on Google Icon
1/14/2026Exchange Traded Concepts LLC15,528$1.05M0.0%+20.6%0.013%Search for SEC Filing on Google Icon
1/14/2026Net Worth Advisory Group6,817$0.46M0.1%+18.5%0.006%Search for SEC Filing on Google Icon
1/13/2026Dakota Wealth Management8,035$0.54M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/13/2026Norden Group LLC11,690$0.79M0.1%-4.5%0.010%Search for SEC Filing on Google Icon
1/9/2026Congress Asset Management Co.1,302,180$87.64M0.6%-9.4%1.107%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC35,093$2.36M0.0%+35.8%0.030%Search for SEC Filing on Google Icon
1/9/2026Assenagon Asset Management S.A.72,085$4.85M0.0%N/A0.061%Search for SEC Filing on Google Icon
1/8/2026NorthCrest Asset Manangement LLC31,414$2.24M0.0%+2.8%0.027%Search for SEC Filing on Google Icon
1/8/2026Oliver Luxxe Assets LLC42,012$2.83M0.4%+0.5%0.036%Search for SEC Filing on Google Icon
1/8/2026Occidental Asset Management LLC6,795$0.46M0.1%-12.2%0.006%Search for SEC Filing on Google Icon
1/7/2026Tealwood Asset Management Inc.18,242$1.23M0.6%-1.5%0.016%Search for SEC Filing on Google Icon
1/7/2026Tealwood Asset Management Inc.18,242$1.23M0.6%-1.5%0.016%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Halozyme Therapeutics logo
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Read More on Halozyme Therapeutics

Today's Range

Now: $77.94
Low: $76.11
High: $78.27

50 Day Range

MA: $69.01
Low: $61.87
High: $76.48

52 Week Range

Now: $77.94
Low: $47.50
High: $79.50

Volume

1,719,925 shs

Average Volume

1,954,123 shs

Market Capitalization

$9.17 billion

P/E Ratio

16.41

Dividend Yield

N/A

Beta

0.97

Who are the company insiders with the largest holdings of Halozyme Therapeutics?

Halozyme Therapeutics' top insider shareholders include:
  1. Helen Torley (CEO)
  2. Michael J Labarre (SVP)
  3. Matthew L Posard (Director)
  4. Bernadette Connaughton (Director)
  5. Jeffrey William Henderson (Director)
  6. Nicole Labrosse (CFO)
  7. Cortney Caudill (COO)
Learn More about top insider investors at Halozyme Therapeutics.

Who are the major institutional investors of Halozyme Therapeutics?

Halozyme Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 9.84%
  2. Congress Asset Management Co. — 1.11%
  3. Boston Trust Walden Corp — 0.66%
  4. Retirement Systems of Alabama — 0.32%
  5. Swedbank AB — 0.14%
  6. Assetmark Inc. — 0.12%
Learn More about top institutional investors of Halozyme Therapeutics stock.

Which major investors are selling Halozyme Therapeutics stock?

Within the last quarter, HALO stock was sold by these institutional investors:
  1. Congress Asset Management Co.
  2. Vanguard Group Inc.
  3. Danske Bank A S
  4. Boston Trust Walden Corp
  5. Horizon Investments LLC
  6. Choreo LLC
  7. M&T Bank Corp
  8. CWM LLC
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
  1. Helen Torley (CEO)
  2. Michael J Labarre (SVP)
  3. Matthew L Posard (Director)
  4. Bernadette Connaughton (Director)
  5. Jeffrey William Henderson (Director)
  6. Nicole Labrosse (CFO)
Learn More investors selling Halozyme Therapeutics stock.

Which major investors are buying Halozyme Therapeutics stock?

Within the last quarter, HALO stock was acquired by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Tema Etfs LLC
  3. Asset Management One Co. Ltd.
  4. Hussman Strategic Advisors Inc.
  5. Paragon Capital Management Inc.
  6. Element Squared LLC
  7. BOKF NA
  8. Swedbank AB